BCI Pharma and Mithra will start a collaboration to deliver new therapy for women! Mithra acquires the rights relating to BCI development program on innovative inhibitors of CSF1R kinase indicated for the treatment of female cancers and endometriosis. Press release
The Internet user may be required to provide certain personal data by completing the forms offered on the Site. The entry of this data is necessary for the processing of the internet user’s request by the BCI PHARMA Company.BCI PHARMA undertakes to comply with the provisions of law n ° 78-17 of 6 January 1978 relating to data processing, files and modified freedoms and to Regulation (EU) 2016/679 of the European Parliament and of the Council of April 27, 2016 known as « RGPD » and take all necessary precautions to preserve the security of personal information entrusted.
The BCI PHARMA Company processes the personal data of Internet users in its capacity as data controller.
Personal data processed and purposes of processing
BCI PHARMA collects personal data on the Site from Internet users who have contacted it, in particular via the online contact form, estimator or by subscribing to the newsletter. These data are necessary in order to respond to the request of Internet users. As part of the provision of its services, the BCI PHARMA Company only processes the following personal data strictly necessary for their contact request: last name, first name, email address, telephone, address, postal code, city.The purpose of processing this personal data is to allow the BCI PHARMA Company to respond to requests from Internet users.BCI PHARMA keeps a written record of the processing of personal data processed on the Site.
Recipients of personal data
Personal data collected on the Site is processed only by members of the BCI PHARMA Company team.Personal data is stored on hosting servers located in the European Union by the company OVH. Internet users are informed that their personal data will be subject to the same protection as that required in Europe insofar as OVH has an obligation to comply with the GDPR concerning the personal data of European citizens.
Retention period of personal data
The BCI PHARMA Company undertakes to keep this personal data, unless there is a legal or regulatory obligation to the contrary, for a maximum period of three years from the last contact with the Internet user, whether at the initiative of the BCI PHARMA Company. or the Internet user (eg sending the newsletter).At the end of this period or in the event of the exercise of its rights by Internet users, BCI PHARMA undertakes to destroy any copy of the personal data of Internet users that it holds.
Security of personal data
BCI PHARMA undertakes, under its obligation of means, to take all useful precautions and implements appropriate technical and organizational measures in this area to guarantee an appropriate level of security and to protect the personal data of Internet users. against alterations, destruction and unauthorized access.
Internet users’ rights over their personal data
Internet users have the possibility to exercise their rights of access, rectification, erasure, opposition, limitation of processing, portability of their personal data, the right not to be the subject of an individual decision. automated system and the right to revoke their consent, regarding the personal data they provide.To exercise one of these rights, you should send your request by email to the following address: dominique.surleraux (@) bci-pharma.com. The BCI PHARMA Company undertakes to respond as soon as possible and at the latest within one month of receipt of the request.If Internet users consider that the processing of their personal data constitutes a violation of the legislation in force, Internet users have the option of lodging a complaint with the CNIL.
Confidentiality of personal data
BCI PHARMA guarantees the confidentiality of the personal data processed and ensures that the persons authorized to process said personal data also undertake to comply with this obligation of confidentiality.
Browsing the Site may result in the installation of cookies on the user’s computer.The data obtained by means of these cookies are intended to facilitate subsequent navigation on the Site and are intended to allow various measures of attendance on the Site.The user of the Site has the option of deactivating cookies by going to the options of his browser.
BCI PHARMA uses Google Analytics to track Internet users on this Site.Cookies are used by Google Analytics to collect this data.In order to comply with the new regulations, Google have included a modification to the processing of data that Internet users can consult on the following pages: Link